# QUANTUM MILESTONE 5.14.1 — DEFLATED SHARPE RATIO FORENSICS
## Mathematical Anatomy of the 1.000000 DSR Artifact & Multiple Testing Correction

**Project:** QUANTUM Multi-Agent Intraday Crypto Perpetual Futures Research System  
**Repository:** `d:/quantum-multi-agent`  
**Branch:** `research/quantum-next-3pct`  
**Baseline Commit:** `0088b65`  
**Audit Target:** M5.14 Deflated Sharpe Ratio (DSR) Implementation  
**Associated Artifact:** `M5_14_1_DSR_RECONCILIATION.csv`

---

## 1. EXECUTIVE SUMMARY & FORENSIC FINDING

In Milestone 5.14, every single one of the 12 configurations reported an identical metric:
$$\text{deflated\_sharpe\_ratio} = \mathbf{1.000000}$$

An invariant result of exactly 1.000000 across radically different portfolio architectures (1-slot 98% vs 4-slot 24.5%) and fee structures (7.0 bps Maker vs 26.0 bps Taker) is a statistical red flag.

### The Forensic Verdict on DSR:
> [!WARNING]
> **STATISTICAL DISCOVERY — NUMERICAL SATURATION ARTIFACT:**  
> The reported value of 1.000000 was **NOT** proof of absolute statistical immunity to backtest overfitting. It was a **numerical saturation artifact** produced by a combination of:
> 1. **Zero-Return Day Filtering:** Feeding an active-day return series ($N=576$) into DSR while omitting calendar days with zero trades, artificially inflating the annualized Sharpe ratio from 2.84–5.39 up to 4.38–7.48.
> 2. **Gaussian Distribution Assumption:** Ignoring return asymmetry (skewness $\hat{\gamma}_3 \approx 2.7$ to $5.5$) and extreme fat tails (kurtosis $\hat{\gamma}_4 \approx 25$ to $50$).
> 3. **Deficient Trial Modeling:** Assuming $K = 12$ independent trials, ignoring the thousands of parameter grids, factor combinations, and architectural iterations conducted across Milestones 1 through 5.14.
> 4. **Float64 Normal CDF Saturation:** When the standardized test statistic $z$ exceeds $+8.2$, standard IEEE 754 double-precision floating-point arithmetic rounds $\Phi(z)$ to exactly $1.0000000000000000$.

---

## 2. DECONSTRUCTION OF THE M5.14 DSR IMPLEMENTATION

The original implementation in `scripts/run_m5_14_concentrated_velocity.py` (lines 138-146) evaluated:
```python
def dsr(values: Iterable[float], trials: int = 12) -> float:
    a = np.asarray(list(values), dtype=float)
    if len(a) < 3 or a.std(ddof=1) == 0:
        return 0.0
    sharpe = (a.mean() / a.std(ddof=1)) * np.sqrt(365.0)
    sigma = np.sqrt((1.0 + 0.5 * sharpe * sharpe) / len(a))
    expected_max = NormalDist().inv_cdf(1.0 - 1.0 / trials)
    return float(NormalDist().cdf((sharpe - expected_max) / max(sigma, 1e-12)))
```

### Analysis of Defects in this Implementation:
1. **Gaussian Variance Formula:**  
   The formula used for $\sigma$ was $\sqrt{\frac{1 + 0.5 \times \widehat{SR}^2}{N}}$. This formulation assumes that returns are independent and identically distributed (i.i.d.) normal random variables (skewness = 0, kurtosis = 3). For cryptocurrency intraday momentum and breakout returns, kurtosis is routinely above 25.
2. **First-Moment Approximation for Expected Maximum:**  
   The expected maximum of $K$ independent standard normals was approximated simply as `inv_cdf(1 - 1/K)`. The correct Extreme Value Theory formulation (Bailey & López de Prado 2014) utilizes the Euler-Mascheroni constant $\gamma \approx 0.5772156649$:
   $$E[\max_k Z_k] \approx (1 - \gamma) \Phi^{-1}\left(1 - \frac{1}{K}\right) + \gamma \Phi^{-1}\left(1 - \frac{1}{K e}\right)$$
3. **Denominator Scaling Inconsistency:**  
   The implementation annualized Sharpe by $\sqrt{365}$, but divided the difference by $\sigma$ computed from sample length $N$ without reconciling the annualization factor.
4. **Saturation Behavior:**  
   For $S_{\text{ann}} = 7.0$ and $N = 576$, $\sigma \approx \sqrt{(1 + 24.5)/576} \approx 0.210$. For $K = 12$, `expected_max` $= \Phi^{-1}(11/12) \approx 1.383$.  
   Then:
   $$z = \frac{7.0 - 1.383}{0.210} \approx \frac{5.617}{0.210} \approx \mathbf{26.75}$$
   In standard normal distributions:
   $$\Phi(26.75) = 1 - 10^{-158} \xrightarrow{\text{IEEE 754 Float64}} \mathbf{1.0000000000000000}$$
   Every configuration's test statistic fell into the saturation zone ($z \in [18, 32]$).

---

## 3. INDEPENDENT RE-EVALUATION UNDER BAILEY & LÓPEZ DE PRADO (2014)

The authoritative formulation accounts for non-normality via Mertens (2002) and adjusts for selection bias:
$$\sigma_{SR} = \sqrt{\frac{1 - \hat{\gamma}_3 \widehat{SR} + \frac{\hat{\gamma}_4 - 1}{4} \widehat{SR}^2}{N - 1}}$$
$$E[\max_k Z_k] \approx (1 - \gamma) \Phi^{-1}\left[1 - \frac{1}{K}\right] + \gamma \Phi^{-1}\left[1 - \frac{1}{K e}\right]$$
$$z = \frac{\widehat{SR}}{\sigma_{SR}} - E[\max_k Z_k]$$
$$\text{DSR} = \Phi(z)$$

### Audited DSR Results (Sourced from `M5_14_1_DSR_RECONCILIATION.csv`):

| Portfolio Mode | Execution Regime | Daily Sharpe (Ann.) | Active Sharpe (Ann.) | Daily Kurtosis ($\hat{\gamma}_4$) | DSR ($K=12$) | DSR ($K=100$) | DSR ($K=1,000$) | DSR ($K=10,000$) |
|---|---|---|---|---|---|---|---|---|
| **Legacy 4-Slot** | Aster Maker (11.0 bps) | 5.06 | 6.99 | 50.06 | 1.000000 | 1.000000 | 1.000000 | 1.000000 |
| **Legacy 4-Slot** | Bybit Maker (7.0 bps) | 5.31 | 7.31 | 49.73 | 1.000000 | 1.000000 | 1.000000 | 1.000000 |
| **Legacy 4-Slot** | Bybit Hybrid (11.0 bps) | 5.02 | 6.97 | 49.75 | 1.000000 | 1.000000 | 1.000000 | 1.000000 |
| **Legacy 4-Slot** | Aster Taker (26.0 bps) | 3.80 | 5.44 | 50.09 | 1.000000 | 1.000000 | 0.999999 | 0.999999 |
| **Mode A Sniper** | Aster Maker (11.0 bps) | 4.44 | 6.31 | 27.46 | 1.000000 | 1.000000 | 0.999999 | 0.999999 |
| **Mode A Sniper** | Bybit Maker (7.0 bps) | 4.78 | 6.73 | 27.75 | 1.000000 | 1.000000 | 1.000000 | 0.999999 |
| **Mode A Sniper** | Bybit Hybrid (11.0 bps) | 4.41 | 6.29 | 27.38 | 1.000000 | 1.000000 | 0.999999 | 0.999999 |
| **Mode A Sniper** | Aster Taker (26.0 bps) | 2.84 | 4.38 | 25.78 | 0.999981 | 0.999438 | **0.994341** | **0.973023** |
| **Mode B Dual-Slot** | Aster Maker (11.0 bps) | 5.08 | 7.10 | 35.55 | 1.000000 | 1.000000 | 1.000000 | 1.000000 |
| **Mode B Dual-Slot** | Bybit Maker (7.0 bps) | 5.39 | 7.48 | 35.23 | 1.000000 | 1.000000 | 1.000000 | 1.000000 |
| **Mode B Dual-Slot** | Bybit Hybrid (11.0 bps) | 5.05 | 7.08 | 35.50 | 1.000000 | 1.000000 | 1.000000 | 1.000000 |
| **Mode B Dual-Slot** | Aster Taker (26.0 bps) | 3.61 | 5.29 | 35.81 | 0.999999 | 0.999999 | 0.999999 | 0.999999 |

---

## 4. MULTIPLE TESTING ADJUSTMENT & TRIAL DEFLATION

When adjusting for true research trial counts:
- In `Mode A Sniper AsterDEX Retail Taker`:
  - With $K = 12$: $\text{DSR} = 0.999981$
  - With $K = 100$: $\text{DSR} = 0.999438$
  - With $K = 1,000$: $\text{DSR} = 0.994341$
  - With $K = 10,000$: $\text{DSR} = 0.973023$

For the maker regimes, DSR remains near 1.0 because the historical simulated equity growth over 1,096 days is substantial enough that even under $K = 10,000$ trials, the null hypothesis of zero true alpha is rejected.

### Crucial Caveat: In-Sample Selection vs Prospective Out-of-Sample
DSR measures whether an in-sample Sharpe ratio is likely to be a lucky artifact given $K$ trials. It **does NOT** guarantee out-of-sample persistence if:
1. Market microstructure changes (queue priority degrades).
2. Volatility regimes shift (1h ATR percentiles fail to identify expansions).
3. Execution model underestimates adverse selection.

---

## 5. SUMMARY OF DSR CORRECTIVE RECOMMENDATIONS

1. **Retire Naive Standard Normal DSR:** Never use Gaussian DSR without kurtosis adjustment on crypto perpetual return data.
2. **Mandate Calendar-Day Sampling:** Always evaluate DSR across the complete calendar timeline ($N = 1,096$), including non-trading days.
3. **Report Multiple Testing Sensitivity:** Report DSR across a trial spectrum $K \in [12, 1000, 10000]$ rather than a single handpicked trial count.
